Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Moertel

Showing results (191-200 of 251) with videos related to

Pageof 26
Sort By:
JAMA|February 13, 1981
A pharmacologic and toxicological study of amygdalinC G Moertel, M M Ames, J S Kovach, et al.
Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1987
Colorectal cancer. Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy patternN A Scott, H S Wieand, C G Moertel, et al.
Cancer Clinical Trials|January 1, 1981
A controlled clinical and immunological evaluation of immunotherapy with Bacillus Calmette--Guerin in patients with metastatic cancerM J O'Connell, R E Ritts, C G Moertel, et al.
International Journal of Cancer|August 15, 1978
A prospective evaluation of the leukocyte adherence inhibition test in colorectal cancer and its correlation with carcinoembryonic antigen levelsA Shani, R E Ritts, G S Thynne, et al.
Cancer|June 1, 1979
A phase I study of chlorozotocin (NSC 178248)J S Kovach, C G Moertel, A J Schutt, et al.
The New England Journal of Medicine|September 27, 1979
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trialE T Creagan, C G Moertel, J R O'Fallon, et al.
Annals of Internal Medicine|August 1, 1987
Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995)L K Kvols, M Buck, C G Moertel, et al.
Cancer|May 1, 1989
Patterns of occult bleeding in asymptomatic colorectal cancerD A Ahlquist, D B McGill, J L Fleming, et al.
Cancer Treatment Reports|September 1, 1983
Pharmacokinetics of mitomycin C in patients receiving the drug alone or in combinationG A van Hazel, M Scott, J Rubin, et al.
Progress in Clinical and Biological Research|January 1, 1989
Cancer control research in the North Central Cancer Treatment Group (NCCTG)C L Loprinzi, A W Miser, C Kardinal, et al.
Pageof 26

Showing results (191-200 of 251) with videos related to

Sort By:
Pageof 26
JAMA|February 13, 1981
A pharmacologic and toxicological study of amygdalinC G Moertel, M M Ames, J S Kovach, et al.
Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1987
Colorectal cancer. Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy patternN A Scott, H S Wieand, C G Moertel, et al.
Cancer Clinical Trials|January 1, 1981
A controlled clinical and immunological evaluation of immunotherapy with Bacillus Calmette--Guerin in patients with metastatic cancerM J O'Connell, R E Ritts, C G Moertel, et al.
International Journal of Cancer|August 15, 1978
A prospective evaluation of the leukocyte adherence inhibition test in colorectal cancer and its correlation with carcinoembryonic antigen levelsA Shani, R E Ritts, G S Thynne, et al.
Cancer|June 1, 1979
A phase I study of chlorozotocin (NSC 178248)J S Kovach, C G Moertel, A J Schutt, et al.
The New England Journal of Medicine|September 27, 1979
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trialE T Creagan, C G Moertel, J R O'Fallon, et al.
Annals of Internal Medicine|August 1, 1987
Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995)L K Kvols, M Buck, C G Moertel, et al.
Cancer|May 1, 1989
Patterns of occult bleeding in asymptomatic colorectal cancerD A Ahlquist, D B McGill, J L Fleming, et al.
Cancer Treatment Reports|September 1, 1983
Pharmacokinetics of mitomycin C in patients receiving the drug alone or in combinationG A van Hazel, M Scott, J Rubin, et al.
Progress in Clinical and Biological Research|January 1, 1989
Cancer control research in the North Central Cancer Treatment Group (NCCTG)C L Loprinzi, A W Miser, C Kardinal, et al.
Pageof 26